References and General Publications

Barlow DH, Cardozo LD, Francis RM, et al. Urogenital ageing and its effect on sexual health in older British women. BJOG 1997;104:87–91.

 

Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med. 2005;2(Suppl 3):154-165.

 

Goldstein I. Recognizing and treating urogenital atrophy in postmenopausal women. J Women’s Health. 2010;19(3):425-432.

 

Ghumman S. Atrophic Vaginitis: Diagnosis and Treatment. J South Asian Feder Menopause Soc 2013; 1(1):4-12.

 

Johnston SL, Farrell SA. The detection and management of vaginal atrophy. SOGC Clinical Practice Guidelines. No. 145, May 2004.

 

Kingsberg SA, Kellogg S, Krychman M. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy. International Journal of Women’s Health, 2009:1 105-111.

 

Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal Atrophy. Mayo Clin Proc. January 2010;85(1):87-94 DOI:10.4065/mcp.2009.0413.

 

NHS Direct. Accessed 30 September 2013 http://www.nhsdirect.nhs.uk/~/media/Selfcare/FemaleSexualHealth/VaginalDryness.ashx

 

Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P, Marrè GB. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung. 2006;56(3):230-8.

 

Santos I, Clissold S. Urogenital disorders associated with oestrogen deficiency: The role of promestriene as topical oestrogen therapy. Gynecological Endocrinology, 2010, 26, 644-651. DOI:10.3109/09513591003767948.

 

Suckling JA, Kennedy R, Lethaby A, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD001500. DOI:10.1002/14651858.CD001500.pub2.

 

Van Geelen JM, van de Weijer PH, Arnolds HT. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50–75 years. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:9–14.